X4 Pharmaceuticals XFOR Q1 2025 earnings
Reported May 1, 2025 · Before market open
Revenue$28.8MBeat by $26.9M
EPS$0.04Beat by $4.17
Revenue estimate$1.9M
EPS estimate-$4.13
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$2.4M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
Ask the moment X4 Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did X4 Pharmaceuticals report Q1 2025 earnings?
- X4 Pharmaceuticals (XFOR) reported Q1 2025 earnings on May 1, 2025 before market open.
- What were X4 Pharmaceuticals's Q1 2025 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $28.8M and eps of $0.04 for Q1 2025.
- Did X4 Pharmaceuticals beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $1.9M by $26.9M. EPS beat the consensus estimate of $-4.13 by $4.17.
- Where can I find X4 Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-021358) directly on SEC EDGAR. The filing index links above go to sec.gov.